About Shriners Hospitals for Children Canada Established in Montreal in 1925, Shriners Hospitals for Children Canada is a bilingual, short-term, acute care hospital, providing ultra-specialized orthopaedic care to children from across Canada and around the world. The mission of the hospital is to provide treatment and rehabilitation to infants, children and young adults with orthopaedic and neuromuscular problems such as scoliosis, osteogenesis imperfecta (brittle bone disease), clubfeet, hip dysplasia, leg length discrepancies and cerebral palsy, among others. The hospital is committed to excellence and innovation in clinical practice, research and education. Affiliated with McGill University, the hospital provides clinical experience and teaching for residents and allied professionals within its outstanding new facility on the Glen site. The hospital is present in communities across Canada, thanks to telemedicine, outreach clinics and satellite clinics.
London, United Kingdom, Aug. 02, 2025 (GLOBE NEWSWIRE) -- MGPD Finance Limited, doing business as HashJ, today announced the official launch of its short-term contracts dedicated to Shiba Inu Coin (SHIB), one of the most community-driven digital assets in the market. The new offering allows everyday users to engage with SHIB-linked reward plans designed for shorter durations and predictable outcomes—particularly as SHIB’s utility and adoption continue to expand globally.
TORONTO, Aug. 1, 2025 /CNW/ - Today, Aegis Brands Inc. (TSX: AEG) reports financial results for the second quarter ending June 29th, 2025.
Highlights for the...
The dynamics of the osteosarcoma market are anticipated to change due to the extensive R&D activities, entry of novel potential therapies such as HALMB-0168...
The dynamics of the osteosarcoma market are anticipated to change due to the extensive R&D activities, entry of novel potential therapies such as HALMB-0168...
SAN DIEGO and NEWPORT BEACH, Calif., July 30, 2025 /PRNewswire/ -- H2O Audio, the leader in waterproof, high-performance multisport headphones, has partnered with Florence...
– Nuvisertib (TP-3654), an oral investigational highly selective PIM-1 kinase inhibitor, is being evaluated in patients with relapsed or refractory myelofibrosis (MF) –
MARLBOROUGH, Mass.,...
SINGAPORE, July 29, 2025 /PRNewswire/ -- Singapore's vibrant CBD culinary scene welcomes a fresh perspective with the opening of American Mass Hall, a new dining...
DELRAY BEACH, Fla., July 28, 2025 /PRNewswire/ -- The global Biosurgery Market, valued at US$14.96 billion in 2024 stood at US$15.83 billion in 2025 and...
DELRAY BEACH, Fla., July 28, 2025 /PRNewswire/ -- The global Biosurgery Market, valued at US$14.96 billion in 2024 stood at US$15.83 billion in 2025 and...